144 related articles for article (PubMed ID: 34611473)
1. Identification of Smurf2 as a HIF-1α degrading E3 ubiquitin ligase.
Zhao S; El-Deiry WS
Oncotarget; 2021 Sep; 12(20):1970-1979. PubMed ID: 34611473
[TBL] [Abstract][Full Text] [Related]
2. Role of the C-terminal alpha-helical domain of the von Hippel-Lindau protein in its E3 ubiquitin ligase activity.
Lewis MD; Roberts BJ
Oncogene; 2004 Mar; 23(13):2315-23. PubMed ID: 14691445
[TBL] [Abstract][Full Text] [Related]
3. HIF-1alpha and EPAS ubiquitination mediated by the VHL tumour suppressor involves flexibility in the ubiquitination mechanism, similar to other RING E3 ligases.
Paltoglou S; Roberts BJ
Oncogene; 2007 Jan; 26(4):604-9. PubMed ID: 16862177
[TBL] [Abstract][Full Text] [Related]
4. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.
Wiesener MS; Münchenhagen PM; Berger I; Morgan NV; Roigas J; Schwiertz A; Jürgensen JS; Gruber G; Maxwell PH; Löning SA; Frei U; Maher ER; Gröne HJ; Eckardt KU
Cancer Res; 2001 Jul; 61(13):5215-22. PubMed ID: 11431362
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
6. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
7. Melatonin and the von Hippel-Lindau/HIF-1 oxygen sensing mechanism: A review.
Vriend J; Reiter RJ
Biochim Biophys Acta; 2016 Apr; 1865(2):176-83. PubMed ID: 26899267
[TBL] [Abstract][Full Text] [Related]
8. Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway.
Isaacs JS; Jung YJ; Mimnaugh EG; Martinez A; Cuttitta F; Neckers LM
J Biol Chem; 2002 Aug; 277(33):29936-44. PubMed ID: 12052835
[TBL] [Abstract][Full Text] [Related]
9. The CDK4/6 inhibitor palbociclib synergizes with irinotecan to promote colorectal cancer cell death under hypoxia.
Zhang J; Zhou L; Zhao S; Dicker DT; El-Deiry WS
Cell Cycle; 2017 Jun; 16(12):1193-1200. PubMed ID: 28486050
[TBL] [Abstract][Full Text] [Related]
10. Dynamic, site-specific interaction of hypoxia-inducible factor-1alpha with the von Hippel-Lindau tumor suppressor protein.
Yu F; White SB; Zhao Q; Lee FS
Cancer Res; 2001 May; 61(10):4136-42. PubMed ID: 11358837
[TBL] [Abstract][Full Text] [Related]
11. Expression of HIF-1 and ubiquitin in conventional renal cell carcinoma: relationship to mutations of the von Hippel-Lindau tumor suppressor gene.
Hughson MD; He Z; Liu S; Coleman J; Shingleton WB
Cancer Genet Cytogenet; 2003 Jun; 143(2):145-53. PubMed ID: 12781449
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the SIAH2-HIF-1 Axis by Protein Kinases and Its Implication in Cancer Therapy.
Xu D; Li C
Front Cell Dev Biol; 2021; 9():646687. PubMed ID: 33842469
[TBL] [Abstract][Full Text] [Related]
13. RACK1 vs. HSP90: competition for HIF-1 alpha degradation vs. stabilization.
Liu YV; Semenza GL
Cell Cycle; 2007 Mar; 6(6):656-9. PubMed ID: 17361105
[TBL] [Abstract][Full Text] [Related]
14. Leu-574 of HIF-1alpha is essential for the von Hippel-Lindau (VHL)-mediated degradation pathway.
Huang LE; Pete EA; Schau M; Milligan J; Gu J
J Biol Chem; 2002 Nov; 277(44):41750-5. PubMed ID: 12205091
[TBL] [Abstract][Full Text] [Related]
15. RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha.
Liu YV; Baek JH; Zhang H; Diez R; Cole RN; Semenza GL
Mol Cell; 2007 Jan; 25(2):207-17. PubMed ID: 17244529
[TBL] [Abstract][Full Text] [Related]
16. Calpain mediates a von Hippel-Lindau protein-independent destruction of hypoxia-inducible factor-1alpha.
Zhou J; Köhl R; Herr B; Frank R; Brüne B
Mol Biol Cell; 2006 Apr; 17(4):1549-58. PubMed ID: 16421254
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of the von Hippel-Lindau protein (VHL) by protein kinase CK2 reduces its protein stability and affects p53 and HIF-1alpha mediated transcription.
Ampofo E; Kietzmann T; Zimmer A; Jakupovic M; Montenarh M; Götz C
Int J Biochem Cell Biol; 2010 Oct; 42(10):1729-35. PubMed ID: 20637892
[TBL] [Abstract][Full Text] [Related]
18. HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation.
Yu F; White SB; Zhao Q; Lee FS
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9630-5. PubMed ID: 11504942
[TBL] [Abstract][Full Text] [Related]
19. Anti-cancer efficacy including Rb-deficient tumors and VHL-independent HIF1α proteasomal destabilization by dual targeting of CDK1 or CDK4/6 and HSP90.
Zhao S; Zhou L; Dicker DT; Lev A; Zhang S; Ross E; El-Deiry WS
Sci Rep; 2021 Oct; 11(1):20871. PubMed ID: 34686682
[TBL] [Abstract][Full Text] [Related]
20. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
Carroll VA; Ashcroft M
Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
